Skip to main content
Clinical Trials/NCT01583673
NCT01583673
Completed
Not Applicable

Assessment of Growth of Infants Fed an Amino Acid Based Formula

Société des Produits Nestlé (SPN)16 sites in 1 country225 target enrollmentMay 2012
ConditionsGrowth

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Growth
Sponsor
Société des Produits Nestlé (SPN)
Enrollment
225
Locations
16
Primary Endpoint
Weight Gain
Status
Completed
Last Updated
10 years ago

Overview

Brief Summary

The primary objective of the clinical trial is to compare growth in infants (expressed as weight gain in g/day) consuming a new Amino Acid Formula to infants consuming a commercially available hypoallergenic formula over a period of 4 months.

Registry
clinicaltrials.gov
Start Date
May 2012
End Date
July 2013
Last Updated
10 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Société des Produits Nestlé (SPN)
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Healthy newborn infant
  • Full-term (\>= 37 weeks gestation)
  • Birth weight between \>= 2500 and \< =4500 g
  • 0-17 days of age on enrolment (day 0 is day of birth)
  • Infant's mother has elected not to breastfeed and to exclusively formula-feed infant
  • Study explained and written information provided with Caregiver demonstrating understanding of the given information
  • Informed consent signed (parent/legal representative)

Exclusion Criteria

  • Congenital illness or malformation that may affect infant feeding and/or normal growth
  • Suspected or known allergy to cow's milk protein
  • Significant pre-natal and/or post-natal disease
  • Any readmission to hospital (except for hyperbilirubinemia) prior to enrolment
  • Infant receiving prescription medication (with exception of topical antibiotics and/or treatment for thrush) or frequent use of over the counter medications except vitamin and mineral supplements
  • Infant currently participating in another conflicting clinical study
  • Infant's family who in the Investigator's assessment cannot be expected to comply with the protocol

Outcomes

Primary Outcomes

Weight Gain

Time Frame: 4 months

Mean weight gain (g/day) from enrollment to 4 months of age

Secondary Outcomes

  • tolerance(4 months)

Study Sites (16)

Loading locations...

Similar Trials